Summit

2018 Summit

2018 KCNQ2 Cure Summit – Ed Cooper – Baylor College of Medicine
The basics of KCNQ2 related epilepsies


2018 KCNQ2 Cure Summit – Ernesto Aycardi – Xenon Pharmaceuticals
Progress in targeting KCNQ2 for the treatment of epilepsy


2018 KCNQ2 Cure Summit – Ingrid Scheffer – University of Melbourne and Florey Institute
KCNQ2 encephalopathy: Facing a new diagnosis and challenges later in life


2018 KCNQ2 Cure Summit – Ed Cooper – Baylor College of Medicine
KCNQ2 related illness—foundational lessons from 600 families participating in research


2018 KCNQ2 Cure Summit – Sarah Weckhuysen – University of Antwerp


2018 KCNQ2 Cure Summit – Phil Pearl – Boston Children’s Hospital
KCNQ2 Natural History and Beyond


2018 KCNQ2 Cure Summit – Dennis Dlugos – Children’s Hospital of Philadelphia
Novel study designs and outcome measures for KCNQ2 epilepsy


2018 KCNQ2 Cure Summit – Glenn King – Institute for Molecular Bioscience
How can venomous animals help us understand and treat genetic epilepsies?